Atlas Trials

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel

Clinical trial NCT05776160 · AVAILABLE

Trial details

NCT number
NCT05776160
Sponsor
Kite, A Gilead Company
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Large B-cell LymphomaFollicular Lymphoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.